Artificial intelligence is changing the game in pharmaceutical R&D—and it's happening faster than most people think. In a recent interview with a California ABC News affiliate, Phil Mounteney, Vice President at Dotmatics, shares how AI is helping pharma companies accelerate drug discovery, reduce development costs, and bring safer, more effective treatments to patients, faster.
“If we can reduce the time and cost to bring a drug to market, we can get drugs to patients more quickly and affordably.” – Phil Mounteney, VP Science & Technology at Dotmatics
In this conversation, Phil also explains:
How AI helped develop the COVID-19 vaccine
Why the FDA is already incorporating AI into regulatory guidance
How the pharma industry is becoming more predictive
What the Luma platform is doing to power this transformation
Watch the full interview to see how Dotmatics is helping shape the future of medicine through scientific intelligence.
Learn More About Dotmatics
Schedule a meeting with our team to learn more about Luma's AI capabilities.